The global blood viscometer market size 2026 was valued at USD 1.68 billion in 2025 and is projected to grow from USD 1.77 billion in 2026 to USD 2.67 billion by 2034, registering a CAGR of 5.2% during the forecast period. Blood viscometers measure the thickness and flow properties of blood and are widely used in the diagnosis and monitoring of cardiovascular disorders, diabetes, stroke, and inflammatory conditions.
Key Market Drivers
Rising Burden of Cardiovascular and Metabolic Diseases is the primary growth driver. Blood viscosity is closely linked to hypertension, stroke risk, and vascular complications, prompting physicians to increasingly incorporate viscosity testing in patient monitoring. The World Health Organization (WHO) reported in September 2025 that approximately 1.4 billion adults globally had hypertension as of 2024, underscoring the clinical need.
Shift Toward Automated and Digital Systems is a key trend reshaping the market. Modern devices offer faster results, greater precision, and integration with laboratory information systems. The use of microfluidic technology — requiring smaller blood samples — is also gaining traction. In February 2026, Anton Paar launched ViscoQC, an automated rotational viscometer designed for streamlined routine viscosity testing.
Market Restraints & Challenges
High Cost of Advanced Devices remains a significant barrier. Fully automated digital systems, priced between USD 2,000 and USD 50,000 (per LabX, February 2025), may be unaffordable for small laboratories or healthcare centers in developing regions. Maintenance, calibration, and the shortage of skilled operators further limit adoption.
Limited Clinical Standardization also challenges the market. Blood viscosity testing is not yet a standard diagnostic procedure across all hospitals, and variations in measurement methods between laboratories reduce result consistency. Regulatory approval processes for new devices add further time and cost burdens for manufacturers.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-viscometer-market-115698
Segmentation Analysis
By Technology
- Capillary Viscometer held the largest market share in 2025, owing to its simplicity, reliability, and cost-effectiveness for routine clinical use.
- Rotational Viscometer is projected to grow at a CAGR of 4.7% through 2034.
By Application
- Clinical Diagnostics & Patient Monitoring dominated with an estimated 72.0% market share in 2026, driven by rising hospital admissions for chronic conditions including cardiovascular disease and diabetes.
- Research is expected to grow at a CAGR of 4.9%, fueled by growing interest in hemorheology for cancer, inflammation, and microcirculation studies.
By End-user
- Hospitals & Diagnostic Laboratories led the segment in 2025, projected to hold 50.1% share in 2026. The U.S. alone had around 6,100 registered hospitals as of 2026 (American Hospital Association), supporting strong testing volumes.
- Academic & Research Institutes are anticipated to grow at a CAGR of 5.0%.
Regional Outlook
Region
2025 Value
2026 Projection
North America
USD 0.69 Bn (41.07% share)
USD 0.62 Bn (U.S. alone)
Europe
—
USD 0.50 Bn (CAGR: 5.2%)
Asia Pacific
—
USD 0.38 Bn
Latin America
—
USD 0.10 Bn
GCC
—
USD 0.04 Bn
North America leads globally, supported by a well-established clinical laboratory network (over 200,000 labs in the U.S. per Laboratory of Florida LLC., February 2026). Asia Pacific is emerging rapidly, driven by government investments in hospital modernization and lab automation. Europe is buoyed by active blood rheology research in stroke and vascular diseases.
Competitive Landscape
RheoSense, Inc., AMETEK Inc., and A&D Company, Limited collectively held the majority of global market share in 2025, backed by strong international presence and high-precision instruments. Other key players include Benson Viscometers, TA Instruments, Cole-Parmer, IKA, LAMY RHEOLOGY, and Hydramotion Ltd.
Notable Developments:
- November 2025: Benson Viscometers showcased its BV1 semi-automated and BV200 automated clinical viscometers at MEDICA 2025 in Düsseldorf.
- July 2025: Biorheologics Co. Ltd. received a U.S. patent for a compact blood viscosity kit using a disposable U-shaped capillary viscometer.
- January 2023: RheoSense unveiled the m-VROC II, measuring viscosity with just 15 microliters of sample at 2% accuracy.
Market Opportunities
Growing pharmaceutical and academic investment in hemorheology research presents significant opportunities. Blood viscosity is increasingly studied in cancer progression, inflammation, and microcirculation disorders, creating demand for advanced microfluidic viscometers and driving collaboration between device makers and research institutions.